Amaero (ASX:3DA) announced a milestone in its commercial trajectory, signing a master purchasing agreement that includes a binding $7.8 million purchase order for its high-specification titanium alloy powders.
The agreement, made with an unnamed private equity-backed manufacturing technology and advanced materials firm, establishes a minimum commitment to be fulfilled through equal quarterly shipments commencing in July and concluding in June 2027.
The contract is a clear indicator of the burgeoning global demand for additive manufacturing materials, particularly within the high-stakes sectors of defence, aerospace, and medical technology.
The company is positioning itself as a leader in the US domestic production of refractory and titanium alloy spherical powders.
By utilising advanced electrode induction-melting gas atomisation technology, Amaero has achieved what it describes as the largest capacity and lowest unit cost production in the United States.
To meet the anticipated surge in volume—with the customer expected to exceed the minimum commitment in FY27—Amaero plans to double its titanium powder production capacity over the coming fiscal year.
Chairman and CEO Hank J. Holland noted that this single contract approximates the company's total titanium powder sales for the entire 2026 fiscal year, providing robust revenue visibility.
Beyond titanium, the company is seeing increased momentum in its refractory alloy segment, with five different high-value alloys currently in production.
The expansion signals Amaero’s transition from development to a high-rate production phase, capitalising on the accelerating adoption of laser powder bed fusion technologies across global industrial markets.